2551 Stock Overview
Shenzhen Glory Medical Co.,Ltd. provides hospital construction and medical system integrated solutions in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Shenzhen Glory Medical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.71 |
| 52 Week High | CN¥4.60 |
| 52 Week Low | CN¥2.11 |
| Beta | -0.010 |
| 1 Month Change | -15.05% |
| 3 Month Change | -27.35% |
| 1 Year Change | -33.25% |
| 3 Year Change | -53.68% |
| 5 Year Change | -55.35% |
| Change since IPO | -64.31% |
Recent News & Updates
Shareholder Returns
| 2551 | CN Construction | CN Market | |
|---|---|---|---|
| 7D | -0.7% | 0.7% | 1.6% |
| 1Y | -33.3% | -24.8% | -15.1% |
Return vs Industry: 002551 underperformed the CN Construction industry which returned -24.8% over the past year.
Return vs Market: 002551 underperformed the CN Market which returned -15.1% over the past year.
Price Volatility
| 2551 volatility | |
|---|---|
| 2551 Average Weekly Movement | 10.0% |
| Construction Industry Average Movement | 8.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 002551's share price has been volatile over the past 3 months.
Volatility Over Time: 002551's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,507 | Guiqiu Liang | www.glory-medical.com.cn |
Shenzhen Glory Medical Co.,Ltd. provides hospital construction and medical system integrated solutions in China and internationally. It operates through Medical Products, Medical Services, and Health Industry segments.
Shenzhen Glory Medical Co.,Ltd. Fundamentals Summary
| 2551 fundamental statistics | |
|---|---|
| Market cap | CN¥2.29b |
| Earnings (TTM) | -CN¥249.66m |
| Revenue (TTM) | CN¥1.25b |
1.8x
P/S Ratio-9.2x
P/E RatioIs 2551 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2551 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.25b |
| Cost of Revenue | CN¥1.04b |
| Gross Profit | CN¥211.26m |
| Other Expenses | CN¥460.92m |
| Earnings | -CN¥249.66m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | -0.30 |
| Gross Margin | 16.84% |
| Net Profit Margin | -19.90% |
| Debt/Equity Ratio | 10.1% |
How did 2551 perform over the long term?
See historical performance and comparison